COVID-19 treatments approved in the European Union and clinical recommendations for the management of non-hospitalized and hospitalized patients
Article
[키워드] addition
affecting
alleviate
antiviral medication
antiviral medicine
approved
Baricitinib
Care
caused
Clinical practice
clinical recommendations
Community
courses
COVID-19
COVID-19 pandemic
COVID-19 patient
COVID-19 treatment
COVID-19 treatments
Critical
deaths
develop
disease
disorder
drug
Dyspnea
effective
effective drugs
European
European Medicines Agency
European Union
Evidence
guidelines.
Health
healthcare
hospital
Hospitalization
Hospitalized
hospitalized patient
hypoxia
Intervention
involved
life-threatening
lung involvement
management
Mild
moderate
molnupiravir
monoclonal antibodies
monoclonal antibody
Most patient
Multiorgan dysfunction
New
outcome
public health
recommendation
Remdesivir
Respiratory failure
rheumatoid arthritis
SARS-CoV-2
Septic shock
severe symptom
Symptom
the disease
the patient
therapy
Thromboembolism
Tocilizumab
treat
Treatment
treatment strategy
union
vaccination
[DOI] 10.1080/07853890.2022.2133162 PMC 바로가기
[DOI] 10.1080/07853890.2022.2133162 PMC 바로가기